NCT00034983View on ClinicalTrials.gov

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

October 29, 2001

Primary Completion Date

December 29, 2003

Study Completion Date

December 29, 2003

Conditions
Major Depressive Disorder
Interventions
DRUG

aprepitant

DRUG

Comparator: paroxetine HCL

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00034983 - Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED) | Biotech Hunter | Biotech Hunter